Annual Review of Cancer Biology

Papers
(The median citation count of Annual Review of Cancer Biology is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
YAP, TAZ, and Hippo-Dysregulating Fusion Proteins in Cancer73
Distinct Essentiality of the Mitochondrial Respiratory Chain in Proliferating Cells In Vivo52
Immune Cell Metabolism and Immuno-Oncology30
Advances in Therapies Targeting Inhibitory Checkpoint Receptors: TIGIT, LAG-3, and Beyond25
Targeting Solid Tumors with Bispecific T Cell Engager Immune Therapy25
Allogeneic CAR T Cell Therapy for Cancer24
Therapeutic Discovery for Chromatin Complexes: Where Do We Stand?23
Cancer Genomic Rearrangements and Copy Number Alterations from Errors in Cell Division22
Caught in a Web: Emerging Roles of Neutrophil Extracellular Traps in Cancer22
Stalled CARs: Mechanisms of Resistance to CAR T Cell Therapies20
Road Map to Defeat Pancreatic Cancer20
Gut Microbiota in Colorectal Cancer: Associations, Mechanisms, and Clinical Approaches19
Cancer Dependency Map: Past and Present19
An Erratic Path Toward Discovery16
The Effects of Clonal Heterogeneity on Cancer Immunosurveillance15
Rationales for Combining Therapies to Treat Cancer: Independent Action, Response Correlation, and Collateral Sensitivity Versus Synergy15
Engineering the Immune Microenvironment into Organoid Models14
Strategies for Heating Up Cold Tumors to Boost Immunotherapies13
Reinventing Radiobiology in the Light of FLASH Radiotherapy12
RB1, Cancer Lineage Plasticity, and Therapeutic Resistance11
Extrachromosomal DNA: Biogenesis and Functions in Cancer11
Targeting Minimal Residual Disease11
Novel Mouse Models for Cancer Immunology10
Mechanism of Action of PARP Inhibitors10
Metabolic Rewiring During Metastasis: The Interplay Between the Environment and the Host10
Not All Carcinogens Are Directly Mutagenic: A Holistic View of the Environmental Exposure–Cancer Connection9
9
Next-Generation Therapies for Multiple Myeloma9
Emerging Mechanisms of Lactate Regulation of Biological Processes8
Targeting BET Bromodomains in Cancer8
Lineage-Specific Transcription Factors in Carcinogenesis8
7
Awakening the Genome: CRISPR Activation to Unravel the Origin and Vulnerabilities of Cancer7
The Metabolic Relationship Between Viral Infection and Cancer7
6
Development of PROTAC Degrader Drugs for Cancer6
Germline Predisposition to Hematopoietic Malignancies: An Overview6
Complex Roles of PTPN11/SHP2 in Carcinogenesis and Prospect of Targeting SHP2 in Cancer Therapy5
New Tools for Lineage Tracing in Cancer In Vivo5
Chemical Proteomics–Guided Discovery of Covalent Ligands for Cancer Proteins5
0.056682825088501